Table 4.
Continuous measure | Clinical definitionb | |||||||
---|---|---|---|---|---|---|---|---|
Measures | Mean ± SE | Multivariate- adjustedc |
n (%) | Multivariate- adjustedd |
||||
Boys | Girls | β | 95% CI | Boys | Girls | OR | 95% CI | |
Systolic blood pressure (in mmHg) | ||||||||
Higher-income nonparticipants | 112.7 ± 0.5 | 107.2 ± 0.4 | Ref. | 60 (3.9) | 10 (2.1) | Ref. | ||
Income-eligible nonparticipants | 112.6 ± 0.7 | 107.0 ± 0.5 | 0.02 | −0.13, 0.18 | 39 (4.8) | 9 (0.8) | 0.93 | 0.46, 1.87 |
SNAP participants | 111.7 ± 0.6 | 107.2 ± 0.6 | 0.03 | −0.14, 0.20 | 26 (7.3) | 10 (1.1) | 1.09 | 0.44, 2.71 |
Fasting triglycerides (in mg/dL) | ||||||||
Higher-income nonparticipants | 88.1 ± 3.6 | 87.7 ± 4.2 | Ref. | 41 (9.9) | 28 (11.3) | Ref. | ||
Income-eligible nonparticipants | 91.9 ± 4.3 | 87.3 ± 4.2 | −0.02 | −0.23, 0.20 | 31 (12.5) | 22 (9.5) | 1.09 | 0.40, 2.94 |
SNAP participants | 92.5 ± 5.0 | 88.2 ± 4.6 | 0.10 | −0.11, 0.31 | 23 (11.4) | 19 (9.8) | 1.37 | 0.49, 3.79 |
HDL cholesterol (in mg/dL) | ||||||||
Higher-income nonparticipants | 49.0 ± 0.5 | 54.3 ± 0.7 | Ref. | 198 (23.7) | 194 (25.6) | Ref. | ||
Income-eligible nonparticipants | 49.2 ± 0.7 | 54.4 ± 0.6 | −0.03 | −0.21, 0.15 | 166 (24.5) | 175 (24.4) | 1.02 | 0.70, 1.49 |
SNAP participants | 49.5 ± 0.7 | 52.4 ± 0.7 | −0.13 | −0.32, 0.06 | 136 (28.8) | 194 (31.5) | 1.36f | 0.86, 2.17 |
Fasting glucose (in mg/dL) | ||||||||
Higher-income nonparticipants | 96.4 ± 1.0 | 91.7 ± 0.6 | Ref. | 85 (24.3) | 28 (10.6) | Ref. | ||
Income-eligible nonparticipants | 96.1 ± 1.6 | 91.5 ± 0.7 | 0.12 | −0.13, 0.36 | 66 (21.3) | 33 (11.5) | 0.96 | 0.48, 1.90 |
SNAP participants | 96.7 ± 2.0 | 94.3 ± 2.1 | 0.29 | 0.04, 0.53 | 85 (21.4) | 24 (13.0) | 1.15 | 0.56, 2.35 |
Cardiometabolic risk (Z score)e | ||||||||
Higher-income nonparticipants | 0.7 ± 0.2 | −0.5 ± 0.2 | Ref. | 28 (7.3) | 16 (6.0) | Ref. | ||
Income-eligible nonparticipants | 0.6 ± 0.2 | −0.5 ± 0.2 | 0.20 | −0.40, 0.80 | 19 (6.9) | 16 (5.2) | 1.16 | 0.51, 2.60 |
SNAP participants | 0.5 ± 0.3 | −0.2 ± 0.3 | 0.75f | 0.02, 1.49 | 17 (7.9) | 12 (4.8) | 1.59 | 0.67, 3.77 |
Note: Boldface indicates statistical significance (p<0.05).
Z scores derived from analytic sample
International Diabetes Federation criteria used to define age-appropriate clinical cutpoints for cardiometabolic risk factors: Waist circumference ≥90th percentile or BMI-for-age ≥95th percentile and the presence of ≥2 risk factors: elevated triglycerides (≥150 mg/dL), low HDL-cholesterol (<40 mg/dL in boys, <50 mg/dL in girls), elevated blood pressure (≥130/ ≥85 mmHg), and elevated fasting glucose (≥100 mg/dL).
Multivariate linear regression models were fit for continuous measures converted to Z scores and adjusted for adolescent’s age, adolescent’s gender, adolescent’s race/ethnicity, parental birth place, parental educational attainment, parental marital status, household size, household income, household WIC participation, and household food insecurity.
Multivariate logistic regression models adjusted for adolescent’s age, adolescent’s gender, adolescent’s race/ethnicity, parental birth place, parental educational attainment, parental marital status, household size, household income, household WIC participation, and household food insecurity.
As a continuous outcome, cardiometabolic risk was defined as the summation of the systolic blood pressure, fasting triglycerides, HDL cholesterol (inverse), and fasting glucose Z scores, with a higher score denoting higher cardiometabolic risk. As a dichotomous outcome, the metabolic syndrome was defined as waist circumference ≥90th percentile or BMI-for-age ≥95th percentile, and the presence of adverse levels of ≥2 risk factors.
p<0.05 comparing SNAP participants to income-eligible nonparticipants.
SNAP, Supplemental Nutrition Assistance Program, NHANES, National Health and Nutrition Examination Survey; HDL, high-density lipoprotein; WIC, Special Supplemental Nutrition Program for Women, Infants and Children